The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Open accessAbstract
Chronic kidney disease–mineral bone disorder (CKD-MBD) is defined by abnormalities in mineral and hormone metabolism, bone histomorphometric changes, and/or the presence of soft-tissue calcification. Emerging evidence suggests that features of CKD-MBD may occur early in disease progression and are associated with changes in osteocyte function. To identify early changes in bone, we utilized the jck mouse, a genetic model of polycystic kidney disease that exhibits progressive renal disease. At 6 weeks of age, jck mice have normal renal function and no evidence of bone disease but exhibit continual decline in renal function and death by 20 weeks of age, when approximately 40% to 60% of them have vascular calcification. Temporal changes in serum parameters were identified in jck relative to wild-type mice from 6 through 18 weeks of age and were subsequently shown to largely mirror serum changes commonly associated with clinical CKD-MBD. Bone histomorphometry revealed progressive changes associated with increased osteoclast activity and elevated bone formation relative to wild-type mice. To capture the early molecular and cellular events in the progression of CKD-MBD we examined cell-specific pathways associated with bone remodeling at the protein and/or gene expression level. Importantly, a steady increase in the number of cells expressing phosphor-Ser33/37-β-catenin was observed both in mouse and human bones. Overall repression of Wnt/β-catenin signaling within osteocytes occurred in conjunction with increased expression of Wnt antagonists (SOST and sFRP4) and genes associated with osteoclast activity, including receptor activator of NF-κB ligand (RANKL). The resulting increase in the RANKL/osteoprotegerin (OPG) ratio correlated with increased osteoclast activity. In late-stage disease, an apparent repression of genes associated with osteoblast function was observed. These data confirm that jck mice develop progressive biochemical changes in CKD-MBD and suggest that repression of the Wnt/β-catenin pathway is involved in the pathogenesis of renal osteodystrophy. © 2012 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Norman, A. W. (1979) · Cited by 3,769
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
MacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Moe, S., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000414 · Cited by 1,993
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B., & Smith, D. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.659 · Cited by 1,684
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Dusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
Epidemiology of cardiovascular disease in chronic renal disease.
Foley, R. N., Parfrey, P. S., & Sarnak, M. J. (1998) · PubMed · Cited by 1,100
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Braun, J., Oldendorf, M., Moshage, W., Heidler, R., Zeitler, E., & Luft, F. C. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90363-7 · Cited by 794
Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease
London, G. M., Marty, C., Marchais, S. J., Guerin, A. P., Metivier, F., & de Vernejoul, M.-C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129337.50739.48 · Cited by 594
Essential role of β-catenin in postnatal bone acquisition.
Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M.-C., Bouxsein, M. L., Deng, L., Clemens, T. L., & Williams, B. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501900200 · Cited by 584
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J. H., Weber, P. B., Feng, J. Q., Bonewald, L. F., & Kneissel, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01428-09 · Cited by 567
The burden of kidney disease: Improving global outcomes
Eknoyan, G., Lameire, N., Barsoum, R., Eckardt, K.-U., Levin, A., Levin, N., Locatelli, F., Macleod, A., Vanholder, R., Walker, R., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00894.x · Cited by 519
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Wijenayaka, A. R., Kogawa, M., Lim, H. P., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025900 · Cited by 503
Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2004) · Circulation Research · doi:10.1161/01.res.0000141775.67189.98 · Cited by 502
Kiel, D. P., Kauppila, L. I., Cupples, L. A., Hannan, M. T., O'Donnell, C. J., & Wilson, P. W. F. (2001) · Calcified Tissue International · doi:10.1007/bf02390833 · Cited by 483
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 390
Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.
Price, P. A., June, H. H., Buckley, J. R., & Williamson, M. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.097102 · Cited by 376
Hak, A. E., Pols, H. A. P., van Hemert, A. M., Hofman, A., & Witteman, J. C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1926 · Cited by 375
Torres, A., Lorenzo, V., Hernández, D., Rodríguez, J. C., Teresa Concepción, M., Rodríguez, A. P., Hernández, A., de Bonis, E., Darias, E., González-Posada, J. M., et al. (1995) · Kidney International · doi:10.1038/ki.1995.201 · Cited by 326
Bone histology in incipient and advanced renal failure
Malluche, H. H., Ritz, E., Lange, H. P., Kutschera, J., Hodgson, M., Seiffert, U., & Schoeppe, W. (1976) · Kidney International · doi:10.1038/ki.1976.42 · Cited by 313
Wallingford, J. B., & Mitchell, B. (2011) · Genes & Development · doi:10.1101/gad.2008011 · Cited by 307
Price, P. A., Faus, S. A., & Williamson, M. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.817 · Cited by 301
Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin
Giachelli, C. M., Speer, M. Y., Li, X., Rajachar, R. M., & Yang, H. (2005) · Circulation Research · doi:10.1161/01.res.0000161997.24797.c0 · Cited by 291
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality
Weiner, D. E., Tighiouart, H., Stark, P. C., Amin, M. G., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.024 · Cited by 276
Craver, L., Marco, M. P., Martinez, I., Rue, M., Borras, M., Martin, M. L., Sarro, F., Valdivielso, J. M., & Fernandez, E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl718 · Cited by 262
Xiao, Z., Zhang, S., Mahlios, J., Zhou, G., Magenheimer, B. S., Guo, D., Dallas, S. L., Maser, R., Calvet, J. P., Bonewald, L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604772200 · Cited by 254
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
Kramer, I., Loots, G. G., Studer, A., Keller, H., & Kneissel, M. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090730 · Cited by 247
Barreto, F. C., Barreto, D. V., Moysés, R. M. A., Neves, K. R., Canziani, M. E. F., Draibe, S. A., Jorgetti, V., & Carvalho, A. B. (2008) · Kidney International · doi:10.1038/sj.ki.5002769 · Cited by 240
Self-citationSclerostin and Dickkopf-1 in Renal Osteodystrophy
Cejka, D., Herberth, J., Branscum, A. J., Fardo, D. W., Monier-Faugere, M.-C., Diarra, D., Haas, M., & Malluche, H. H. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06550810 · Cited by 240
Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy
Wallin, R., Wajih, N., Greenwood, G. T., & Sane, D. C. (2001) · Medicinal Research Reviews · doi:10.1002/med.1010 · Cited by 235
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Wan, M., Yang, C., Li, J., Wu, X., Yuan, H., Ma, H., He, X., Nie, S., Chang, C., & Cao, X. (2008) · Genes & Development · doi:10.1101/gad.1702708 · Cited by 231
Smith, L. A., Bukanov, N. O., Husson, H., Russo, R. J., Barry, T. C., Taylor, A. L., Beier, D. R., & Ibraghimov-Beskrovnaya, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020136 · Cited by 200
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
Martin, K. J., Olgaard, K., Coburn, J. W., Coen, G. M., Fukagawa, M., Langman, C., Malluche, H. H., McCarthy, J. T., Massry, S. G., Mehls, O., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.003 · Cited by 175
Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study
Barreto, D. V., Barreto, F. D. C., de Carvalho, A. B., Cuppari, L., Draibe, S. A., Dalboni, M. A., Moyses, R. M. A., Neves, K. R., Jorgetti, V., Miname, M., et al. (2008) · Nephron Clinical Practice · doi:10.1159/000170783 · Cited by 173
Self-citationFerreira, A. A. A., Fraza[Combining Tilde]o, J. T. M., Monier-Faugere, M.-C., Gil, C. A. A., Galvao, J. A. A., Oliveira, C., Baldaia, J., Rodrigues, I., Santos, C., Ribeiro, S., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101089 · Cited by 172
BANKS, L. M., LEES, B., MACSWEENEY, J. E., & STEVENSON, J. C. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02024.x · Cited by 164
A rat model of chronic kidney disease-mineral bone disorder
Moe, S. M., Chen, N. X., Seifert, M. F., Sinders, R. M., Duan, D., Chen, X., Liang, Y., Radcliff, J. S., White, K. E., & Gattone, V. H. (2009) · Kidney International · doi:10.1038/ki.2008.456 · Cited by 163
Lomashvili, K. A., Monier‐Faugere, M., Wang, X., Malluche, H. H., & O'Neill, W. C. (2009) · Kidney International · doi:10.1038/ki.2008.646 · Cited by 158
Barreto, D. V., Barreto, F. C., Carvalho, A. B., Cuppari, L., Cendoroglo, M., Draibe, S. A., Moyses, R. M. A., Neves, K. R., Jorgetti, V., Blair, A., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00239.x · Cited by 158
Self-citationSolal, M. C., Sebert, J., Boudailliez, B., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-3-516 · Cited by 157
Barreto, D. V., Barreto, F. D. C., Carvalho, A. B., Cuppari, L., Draibe, S. A., Dalboni, M. A., Moysés, R. M. A., Neves, K. R., Jorgetti, V., Miname, M. H., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.024 · Cited by 144
Self-citationRenal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
PARFITT, A. M. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200307000-00007 · Cited by 135
Nek8 Regulates the Expression and Localization of Polycystin-1 and Polycystin-2
Sohara, E., Luo, Y., Zhang, J., Manning, D. K., Beier, D. R., & Zhou, J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090985 · Cited by 135
Inducers and inhibitors of biomineralization: lessons from pathological calcification
Giachelli, C. M. (2005) · Orthodontics and Craniofacial Research · doi:10.1111/j.1601-6343.2005.00345.x · Cited by 127
Calcification of the Aorta and Osteoporosis: A Roentgenographic Study
Boukhris, R. (1972) · JAMA · doi:10.1001/jama.219.10.1307 · Cited by 126
Stubbs, J. R., He, N., Idiculla, A., Gillihan, R., Liu, S., David, V., Hong, Y., & Quarles, L. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.516 · Cited by 113
Self-citationLund, R. J., Davies, M. R. P., Brown, A. J., & Hruska, K. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000109671.99498.08 · Cited by 111
Price, P. A., Buckley, J. R., & Williamson, M. K. (2001) · Journal of Nutrition · doi:10.1093/jn/131.11.2910 · Cited by 109
Determinants of coronary artery calcification in diabetics with and without nephropathy
Mehrotra, R., Budoff, M. J., Christenson, P., Ipp, E., Takasu, J., Gupta, A., Norris, K. C., & Adler, S. G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00974.x · Cited by 105
Moe, S. M., Radcliffe, J. S., White, K. E., Gattone, V. H., Seifert, M. F., Chen, X., Aldridge, B., & Chen, N. X. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.485 · Cited by 102
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
Fahrleitner‐Pammer, A., Herberth, J., Browning, S. R., Obermayer-Pietsch, B. M., Wirnsberger, G. H., Holzer, H., Dobnig, H., & Malluche, H. H. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080610 · Cited by 101
Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7
González, E. A., Lund, R. J., Martin, K. J., McCartney, J. E., Tondravi, M. M., Sampath, T. K., & Hruska, K. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00258.x · Cited by 95
β‐Catenin—A supporting role in the skeleton
Case, N. D., & Rubin, J. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22574 · Cited by 92
Pavik, I., Jaeger, P., Kistler, A. D., Poster, D., Krauer, F., Cavelti‐Weder, C., Rentsch, K., Wuthrich, R. P., & Serra, A. L. (2010) · Kidney International · doi:10.1038/ki.2010.375 · Cited by 87
Tomiyama, C., Carvalho, A. B., Higa, A., Jorgetti, V., Draibe, S. A., & Canziani, M. E. F. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090735 · Cited by 87
Self-citationMisconceptions (3): calcium leaves bone only by resorption and enters only by formation
PARFITT, A. M. (2003) · Bone · doi:10.1016/j.bone.2003.05.002 · Cited by 84
The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?
Malluche, H. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1002 · Cited by 81
Impact of Cardiovascular Calcification in Nondialyzed Patients after 24 Months of Follow-up
Watanabe, R., Lemos, M. M., Manfredi, S. R., Draibe, S. A., & Canziani, M. E. F. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06240909 · Cited by 80
Self-citationXiao, Z., Zhang, S., Magenheimer, B. S., Luo, J., & Quarles, L. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710407200 · Cited by 76
Menon, V., & Sarnak, M. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.022 · Cited by 70
Hruska, K. A., Mathew, S., Lund, R. J., Memon, I. A., & Saab, G. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.01.008 · Cited by 60
Gomes, S. A., dos Reis, L. M., Oliveira, I. B., Noronha, I. D. L., Jorgetti, V., & Heilberg, I. P. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0788-2 · Cited by 36
Self-citationThe Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease
(2010) · Oxford University Press eBooks · doi:10.1093/med/9780199559176.001.1 · Cited by 31
Variant of Adynamic Bone Disease in Hemodialysis Patients: Fact or Fiction?
Rocha, L. A., Higa, A., Barreto, F. C., dos Reis, L. M., Jorgetti, V., Draibe, S. A., & Carvalho, A. B. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.028 · Cited by 20
Self-citationIs parathyroid hormone measurement useful for the diagnosis of renal bone disease?
Drüeke, T. B. (2008) · Kidney International · doi:10.1038/sj.ki.5002800 · Cited by 16
Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision
Andress, D. L. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01310307 · Cited by 15
Cited by
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
WNT–β-catenin signalling — a versatile player in kidney injury and repair
Schunk, S. J., Floege, J., Fliser, D., & Speer, T. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00343-w · Cited by 427
Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders
Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91
Hormonal and systemic regulation of sclerostin
Drake, M. T., & Khosla, S. (2017) · Bone · doi:10.1016/j.bone.2016.12.004 · Cited by 77
Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
He, T., Qin, L., Chen, S., Huo, S., Li, J., Zhang, F., Yi, W., Mei, Y., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00424-1 · Cited by 58
Metadata
- Authors
- Sabbagh, Y., Graciolli, F. G., O'Brien, S., Tang, W., dos Reis, L. M., Ryan, S., Phillips, L., Boulanger, J., Song, W., Bracken, C., Liu, S., Ledbetter, S., Dechow, P., Canziani, M. E. F., Carvalho, A. B., Jorgetti, V., Moyses, R. M., & Schiavi, S. C.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-10
- Volume
- 27
- Issue
- 8
- Pages
- 1757-1772
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1987586045
- Cited by
- 254
- References
- 77
- FWCI
- 18.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.